Whittier Daily News

Merck stock jumped Tuesday on a surprise win for its drug, sotatercept, in patients with pulmonary hypertension.

Merck Jumps On A Surprise Win; Why It Still Has A Long Road To Go ↗

November 18, 2025

Via Investor's Business Daily

Topics Government

Top S&P500 movers in Tuesday's pre-market session ↗

November 18, 2025

Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗

November 18, 2025

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model.

Via Investor's Business Daily

Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover ↗

November 17, 2025

Via Stocktwits

Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)

November 18, 2025

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗

November 17, 2025

Via Benzinga

Topics Artificial Intelligence

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Topics ETFs

Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation

November 17, 2025

As November 2025 unfolds, the global financial markets find themselves at a critical juncture, characterized by a palpable sense of unease over elevated valuations in specific sectors and a pronounced...

Discover Merck (MRK), a top value stock with a low P/E ratio, strong profitability, and solid financial health, offering a potential margin of safety.

Topics Artificial Intelligence Bonds Economy

Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗

November 17, 2025

Via Benzinga

MERCK & CO. INC. (NYSE:MRK): A Value Investment with Strong Fundamentals ↗

November 17, 2025

Via Chartmill

These 2 Dividend ETFs Are a Retiree's Best Friend ↗

November 16, 2025

Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.

Via The Motley Fool

Topics Artificial Intelligence Bonds ETFs

AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines

November 14, 2025

The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This...

Via TokenRing AI

Topics Artificial Intelligence Economy Product Recall

AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development

November 14, 2025

The pharmaceutical industry is on the cusp of a profound transformation, driven by the synergistic power of artificial intelligence (AI) and digital twins. These cutting-edge technologies are rapidly...

Via TokenRing AI

Topics Artificial Intelligence

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

The company is getting deeper into the antiviral space, buying a company working on a long-acting drug to protect against flu.

Topics Artificial Intelligence Economy Intellectual Property

Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal ↗

November 14, 2025

Via Investor's Business Daily

Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗

November 14, 2025

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

Via Benzinga

Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio ↗

November 14, 2025

With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications.

Via Stocktwits

Topics Intellectual Property

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

November 14, 2025

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗

November 13, 2025

Via Stocktwits

Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?

November 13, 2025

As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance,...

Topics Artificial Intelligence Economy Stocks

Merck to Participate in the Jefferies Global Healthcare Conference in London

November 13, 2025

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗

November 13, 2025

Via The Motley Fool

Topics Intellectual Property

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors? ↗

November 13, 2025

A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.

Via The Motley Fool

Topics ETFs Economy Retirement

The Data Drought of 2024: Recalling the Urgent Call for November Jobs and CPI Figures Post-Shutdown

November 12, 2025

Washington D.C. – November 12, 2025 – Looking back from today, the critical period following a hypothetical, yet highly plausible, U.S. government shutdown in late 2024 served as a stark reminder of...

Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation

Topics Economy

November 12, 2025

The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by...

New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the...

Topics Artificial Intelligence Economy Stocks

Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution

November 12, 2025

Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions

Topics Artificial Intelligence Economy Stocks

November 12, 2025

The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones...

New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an...

Topics Artificial Intelligence Bonds Economy

Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox

November 12, 2025

Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag

Topics Artificial Intelligence Bonds Economy

November 12, 2025

The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was...